Navigation Links
Allos in Medical News

Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non-Urban Markets

...n approximately 600 companies in 30 countries. The firm has invested more than $6.5 billion in healthcare companies, including investments in allos Therapeutics, American Medical Systems, Bausch & Lomb, Coventry Health Care, Eurand, Euromedic International (acquired by Merrill Lynch Global Pri...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) allos THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq:...

Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing

...iversity, Long Beach. "I am very excited to join allos and lead the Company's manufacturing activities," said Mr. Bennett. "I believe allos has the product candidates and leadership team to ...ew therapies for the treatment of cancer." About allos Therapeutics, Inc. ...

Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference

...ch will be accessible through a link posted on the allos website home page and investor relations section. ... Allos' website through December 28, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focuse...

Allos Therapeutics Reports Third Quarter 2007 Financial Results

...al 480-629-9562. Participants should reference the allos Therapeutics conference call. Conference Call Rep...llos.com and will be archived for 30 days. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...

Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference

...be available for replay on Allos' website through November 20, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...
Allos in Medical Technology

Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma

WESTMINSTER, Colo., Dec. 27 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced that an independent Data Monitoring Committee (DMC) has completed the pre-specified 65-patient safety review of data from the Company's pivotal Phase 2 PROPEL trial of PDX (pralatrex...

Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma

PROPEL Enrollment Ahead of Schedule with Completion Expected Q2 2008 WESTMINSTER, Colo., Sept. 24 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced the completion of pre-planned interim analyses of patient response and safety data from the Company's pivotal ...

William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman

...at Sofinnova Ventures and serves as Chairman of the Board of Directors at Intermune and a member of the Board of Directors of Inspire Pharmaceuticals, allos Therapeutics, Alvine Pharmaceuticals, Portola Pharmaceuticals, and BioCrossroads, a not for profit organization. Mr. Ringo holds a B.S. and an M.B.A. ...

Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma

...mphoma represents approximately 10 percent. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...resentation, except as required by law. Note: The allos logo is a trademark of...

BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer

...t PARP-1 (poly-ADP-ribose polymerase), an enzyme crucial to cell repair and upregulated in certain tumors. Mr. Malek joins BiPar after seven years at allos Therapeutics where, as vice president of corporate development, he played a pivotal role in shifting Allos' strategy to focus solely on oncology asset...

Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma

...otrexate and certain other DHFR inhibitors. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focuse...resentation, except as required by law. Note: The allos logo is a trademark of...

Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission

...irst-line or relapsed or refractory PTCLs. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...pt as required by law. Note: EFAPROXYNTM and the allos logo are trademarks of Allos Therapeutics, Inc. ...

Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer

...1-689-8567. Call participants should reference the allos Therapeutics conference call. Conference Call Re...los.com and will be archived for 30 days. About allos allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...
Allos in Medical Definition

Allopathic medicine

...the symptoms. Often contrasted with homeopathy." [2] Other sources define allopathic medicine more in accord with the meaning of its word parts, allos meaning opposite and path meaning disease . Steadman's Medical Dictionary calls it a "therapeutic system in which a disease is treated by prod...
Allos in Biological Technology

OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development

...ale of that company to Sanofi-Aventis in April of this year. Previously, he held senior corporate development, marketing, and strategy positions with allos Therapeutics, Connetics Corporation, Abgenix and Gilead Sciences. Mr. Patel also served as a consultant with McKinsey & Company. Earlier in his ...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...SDAQ: ALXN ) ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) allos THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ...TM) Emerging Cancer Index (HHJ) Drop AETERNA ZENTARIS INC. (TSE: AEXS) allos THERAPEUTICS INC. (NASDAQ: ALTH ) ARQULE INC. (NASDAQ: ARQL ) ARRAY BIO...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...tics Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) allos THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: A...

Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

...e available for replay on Allos' website through February 22, 2008. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...

Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference

...be available for replay on Allos' website through November 27, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...

Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference

...s referenced above are available for review on the allos website (http://www.allos.com ) under the "Presen...Investor Relations" section of the website. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...

Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference

... be available for replay on Allos' website through October 12, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...

Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference

...e available for replay on Allos' website through September 21, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...
Other Tags
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 Findings ... , Researchers at UC Davis have developed and characterized ... cancer cells, causing them to self-destruct. This novel mechanism ... responsible for a usually fatal type of brain cancer ... cancers. , The article, to be published in ...
(Date:3/3/2015)... 03, 2015 Today the Brain Injury ... of bike, skate, snow, water, and motorcycle helmets, announced ... injury. The partnership kicks off with Nutcase donating $2 ... http://www.nutcasehelmets.com to BIAA during the month of March ... year BIAA leads the nation in observing Brain Injury ...
(Date:3/3/2015)... March 03, 2015 US Air Purifiers ... air purification systems, is pleased to announce that all Rabbit ... supply interruption related to the west coast port strikes. This ... around the corner. , The port strikes, ... to slow fourth quarter economic growth by as much as ...
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 ... allege a metal-on-metal version of the artificial hip ... complications continue to move forward in the federal ... District of Texas. According to the most recent ... March 2, 2015, 7,350 Pinnacle hip replacement lawsuits ...
(Date:3/3/2015)... 2015 With a grant of more ... Center (GHPC) has been named a national coordinating center ... the Bridging for Health: Improving Community Health Through Innovations ... communities improve health and reduce disparities through innovations in ... the work of the center and up to 10 ...
Breaking Medicine News(10 mins):Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial Services ... in the Health and Fitness Industry, today announced ... to MYiCLUBonline.  The latest upgrade includes advances to ... of cardless check-in via Identity One fingerprint biometrics. ... time through interactive displays at the International Health, ...
(Date:2/19/2015)... .19, 2015 Research and Markets ... the "Military Electro-Optical / Infrared Systems Market ... Platform - Forecast to 2020" report to ... systems market is expected to reach $16.35 billion ... This report segments the military electro-optical/infrared ...
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
Other Contents